SS
SURF

Steve Schonfeld’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Steve Schonfeld’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,800
Closed -$138K – 3044
2021
Q4 		$138K Buy
28,800
+14,100
+96% +$91K ﹤0.01% 1833
2021
Q3 		$112K Buy
+14,700
New +$94.1K ﹤0.01% 1906
2021
Q2 		– Sell
-48,522
Closed -$378K – 2430
2021
Q1 		$378K Sell
48,522
-14,746
-23% -$147K ﹤0.01% 1246
2020
Q4 		$585K Sell
63,268
-38,832
-38% -$338K 0.01% 993
2020
Q3 		$704K Buy
102,100
+29,500
+41% +$179K 0.01% 810
2020
Q2 		$476K Buy
+72,600
New +$262K 0.01% 822

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steve Schonfeld's SURF Position: Q1 2022 in Review

Steve Schonfeld sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2022, closing a stake of 28,800 shares — an estimated $138K sold.

Steve Schonfeld first reported a position in SURF in Q2 2020 and held it in 6 quarters. The position peaked at $704K in Q3 2020. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

  • Steve Schonfeld reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Steve Schonfeld sold 28,800 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $138K.
  • Steve Schonfeld first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Steve Schonfeld's Surface Oncology, Inc. Common Stock position peaked at $704K in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2022, filed 16 May 2022.